- US, European markets rise as investors weigh rates, earnings
- In Colombia, children trade plastic waste for school supplies
- JPMorgan Chase profits top estimates, bank sees 'resilient' US economy
- Little progress at key meet ahead of COP29 climate summit
- 'Party atmosphere': Skygazers treated to another aurora show
- Kyrgyzstan opens rare probe into glacier destruction
- European Mediterranean states discuss Middle East, migration
- Thunberg leads pro-Palestinian, climate protest in Milan
- Stock markets diverge before China weekend briefing
- EU questions shopping app Temu over illegal products risk
- Han Kang's books sell out in South Korea after Nobel win
- Shanghai markets sink ahead of briefing on mixed day for Asia
- Investors, analysts eye bigger China stimulus at Saturday briefing
- Musk unveils robotaxi, pledges it 'before 2027'
- At least 11 dead in Florida but Hurricane Milton not as bad as feared
- Asian markets mixed after Wall St drop, Shanghai dips before briefing
- Automaker Stellantis says CEO will retire in 2026
- Musk's promised robotaxi unveil delayed
- On US coast, wind power foes embrace 'Save the Whales' argument
- At least 10 dead in Florida after Hurricane Milton spawns tornadoes
- Internet Archive reels from 'catastrophic' cyberattack, data breach
- Wall Street stocks retreat from records on US inflation data
- Israel strikes central Beirut, killing 22
- Solar storm could impact US hurricane recovery efforts: agency
- Delta eyes Election Day travel pullback as profits climb
- Florida battered by hurricane, floods but spared 'worst-case scenario'
- UK's William and Kate in first joint public engagement since cancer treatment
- Over 200 women in legal talks with Harrods over Fayed abuse claims
- A very stiff breeze: BBC says sorry for 20,000 kph wind forecast
- Musk finally unveiling his long-promised robotaxi
- London's Frieze art fair goes potty for ceramics
- US, Europe stocks fall on US inflation data
- US consumer inflation eases to 2.4% in September
- Hurricane Milton tornadoes kill four in Florida amid rescue efforts
- South Korea's Han Kang wins literature Nobel
- Ikea posts fall in annual sales after lowering prices
- Stock markets diverge, oil gains after China rebounds
- World can't 'waste time' trading climate change blame: COP29 hosts
- South Korean same-sex couples make push for marriage equality
- Mumbai declares day of mourning for Indian industrialist Ratan Tata
- 7-Eleven owner restructures to fight takeover
- Sri Lanka recovering faster than expected: World Bank
- Hong Kong, Shanghai rally as most markets track Wall St record
- Uniqlo owner reports record annual earnings
- Hong Kong, Shanghai rally as markets track Wall St record
- Indonesia biomass drive threatens key forests: report
- Mumbai mourns Indian industrialist Ratan Tata
- China opens $71 bn 'swap facility' to boost markets
- Asian markets track Wall St record as Hong Kong, Shanghai stabilise
- 'Denying my potential': women at Japan's top university call out gender imbalance
RIO | 0.67% | 67.293 | $ | |
BTI | 0.21% | 35.185 | $ | |
BP | -0.48% | 32.185 | $ | |
GSK | -1.15% | 38.765 | $ | |
CMSC | 0.32% | 24.67 | $ | |
RBGPF | -1.03% | 59.49 | $ | |
CMSD | 0.6% | 24.919 | $ | |
RYCEF | 1.71% | 7 | $ | |
AZN | 0.43% | 77.205 | $ | |
NGG | 0.88% | 66.26 | $ | |
SCS | 2.06% | 12.865 | $ | |
RELX | 1.04% | 46.845 | $ | |
VOD | -1.03% | 9.641 | $ | |
JRI | 0.3% | 13.26 | $ | |
BCC | 1.77% | 141.459 | $ | |
BCE | 0.56% | 33.045 | $ |
Sanofi, joining other drug makers, slashes US insulin price
French pharmaceutical giant Sanofi announced on Thursday it would cut the US price of its most prescribed insulin by 78 percent, falling in line with two other major drug makers.
Eli Lilly announced this month it would cut the US price of its insulin by 70 percent and Novo Nordisk followed suit by saying it would lower the price by 75 percent.
The moves come after US President Joe Biden urged insulin manufacturers to lower the price of a life-saving drug needed by millions of Americans living with diabetes.
"Insulin costs less than $10 to make, but Americans are sometimes forced to pay over $300 for it," Biden said.
Sanofi, Eli Lilly and Novo Nordisk dominate the insulin market in the United States.
Sanofi said it would cut the list price of Lantus, its most widely prescribed insulin in the United States, by 78 percent from January 1, 2024.
The company said it would also cap out-of-pocket costs at $35 per month for people with insurance.
"Sanofi believes that no one should struggle to pay for their insulin," Olivier Bogillot, Sanofi's head of US general medicines, said.
"We are proud of our continued actions to improve access and affordability for millions of patients for many years," Bogillot said in a statement.
The incidence of diabetes in the United States in adults has doubled over the last 20 years, afflicting 37.3 million people, according to the US Centers for Disease Control and Prevention.
Insulin prices have soared in the country, with the drug costing over eight times more than in 32 comparable high-income countries, a 2020 Rand Corporation study found.
The unaffordability of insulin -- particularly for uninsured Americans -- has become a rallying cry for critics of Big Pharma.
A.Leibowitz--CPN